Status: current, Defined. Date: 31-Dec 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3159761000168113 | Ilumya (tildrakizumab 100 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3159771000168119 | Ilumya 100 mg/mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Ilumya 100 mg/mL injection, syringe | Is a | Ilumya | true | Inferred relationship | Some | ||
Ilumya 100 mg/mL injection, syringe | Is a | tildrakizumab 100 mg/mL injection, syringe | true | Inferred relationship | Some | ||
Ilumya 100 mg/mL injection, syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Ilumya 100 mg/mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Ilumya 100 mg/mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 2061946555 | |
Ilumya 100 mg/mL injection, syringe | has intended active ingredient | tildrakizumab | true | Inferred relationship | Some | 2061946554 | |
Ilumya 100 mg/mL injection, syringe | has Australian BoSS | tildrakizumab | true | Inferred relationship | Some | 2061946554 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ilumya 100 mg/mL injection, 1 mL syringe | has TPUU | True | Ilumya 100 mg/mL injection, syringe | Inferred relationship | Some | 1 |
Ilumya 100 mg/mL injection, 1 mL syringe | has TPUU | True | Ilumya 100 mg/mL injection, syringe | Inferred relationship | Some | 1 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set